Person

Dr. Eric Hughes

Dr. Eric Hughes — Teva executive vice president and chief medical officer. Every TV10 Global story that covers or mentions Dr. Eric Hughes, translated into English from TV10's Hebrew reporting.

Type
Person

1 story on TV10 Global

Teva stock
Hit a Record High

FDA Approves New Teva Schizophrenia Treatment — Stock Jumps

Teva received approval from the U.S. Food and Drug Administration to market WELTRUZA, intended for adults • The new treatment is based on the active ingredient olanzapine and is administered as a once-monthly subcutaneous injection without the need for loading doses • The drug is expected to be available in the United States in the coming weeks

TV10 Editorial Staff